Propel Drug-Eluting Sinus Stent Family Open Cohort
← catalyst calendarSponsored by Medtronic (industry) · MDT — their whole pipeline →.
Phase
—
Status
Completed
Study type
Observational
Enrollment
215actual
Sites
9
Countries
Germany, United Kingdom
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2023-06-01 | actual | When the study began enrolling |
| Primary completion | 2025-02-19 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-09-01 | actual | The whole study's end, after follow-up |
| First posted | 2023-07-03 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-01-20 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Chronic Rhinosinusitis (Diagnosis)
Intervention
- Other: NA-Observational Registry
Primary outcome
what the primary-completion date above is the date OFLong-term safety and efficacy of corticosteroid-eluting implants in patients with CRS undergoing Functional Endoscopic Sinus Surgery (FESS)
measured 6 months
Permalink · MDT's whole pipeline · Catalyst calendar · Every registered study · What changed